Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF)
2.61
0.00 (0.00%)
USD |
OTCM |
Feb 19, 16:00
Shanghai Fosun Pharmaceutical Shareholders Equity (Quarterly) : 6.747B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Sinovac Biotech Ltd. | -- |
| CASI Pharmaceuticals, Inc. | -25.73M |
| Zai Lab Ltd. | 759.94M |
| WuXi Biologics (Cayman), Inc. | -- |
| Viva Biotech Holdings | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 16.59B |
| Total Liabilities (Quarterly) | 8.051B |
| Debt to Equity Ratio | 0.77 |
| Current Ratio | 0.9162 |
| Net Debt Paydown Yield | -0.69% |